Back to Careers

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health

Back to Careers

Lilly Bites Again in $650M Muscle-Preserving Treatment Pact With Juvena

Back to Careers

Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs

Back to Careers

Juvena Therapeutics Announces Initiation of First-in-Human Clinical Trial of JUV-161

Back to Careers

Juvena Kicks Off First Human Trial of Muscle Regeneration Therapy

Back to Careers

CEO Dr. Hanadie Yousef shares insights on a panel, “Entrepreneurial Excellence in BioPharma: Lessons from the Frontlines,” at SynBioBeta – The Global Synthetic Biology Conference in San Jose

Back to Careers

CEO Dr. Hanadie Yousef shares an Industry Update on JUV-161 and our plans to initiate Phase 1 studies this year at the 2025 International MDF Conference in  Indianapolis

Back to Careers

Dr. Hanadie Yousef gave a talk on “Building a Pipeline with Purpose: Turning a Platform into Strategic Asset Value” as an invited speaker at Fierce Pharma Engage BD&L Summit in San Diego

juvena-logo-wht

Navigation

Contact

640 Galveston Drive
Redwood City, CA 94063
Get Directions »
650.223.5879
info@juvenatherapeutics.com

Stay in touch

Subscribe to our newsletter

By entering your email you agree to our Privacy Policy

© 2023 Juvena Therapeutics Inc. All Rights Reserved | Privacy Policy